These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6174137

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.
    Peckham MJ, Barrett A, McElwain TJ, Hendry WF, Raghavan D.
    Br J Urol; 1981 Apr; 53(2):162-72. PubMed ID: 6165424
    [Abstract] [Full Text] [Related]

  • 3. Tumour-marker levels and prognosis in malignant teratoma of the testis.
    Germa-Lluch JR, Begent RH, Bagshawe KD.
    Br J Cancer; 1980 Dec; 42(6):850-5. PubMed ID: 6161630
    [Abstract] [Full Text] [Related]

  • 4. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours.
    Peckham MJ, Barrett A, Husband JE, Hendry WF.
    Lancet; 1982 Sep 25; 2(8300):678-80. PubMed ID: 6126625
    [Abstract] [Full Text] [Related]

  • 5. Testicular tumour markers in tissue correlated to serum levels and clinical stage.
    Alm P, Hultberg B, Olsson AM.
    Scand J Urol Nephrol; 1984 Sep 25; 18(4):283-8. PubMed ID: 6209794
    [Abstract] [Full Text] [Related]

  • 6. Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis.
    Sogani PC, Whitmore WF, Herr HW, Bosl GJ, Golbey RB, Watson RC, DeCosse JJ.
    J Clin Oncol; 1984 Apr 25; 2(4):267-70. PubMed ID: 6200576
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ, Zborzil J, Sikorowa L, Leńko J, Kamińska JA, Gadek A.
    Oncology; 1983 Apr 25; 40(1):1-10. PubMed ID: 6185897
    [Abstract] [Full Text] [Related]

  • 9. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH, Sleijfer DT, Schraffordt Koops H, De Bruijn HW, Oosterhuis JW, Brouwers TM, Ockhuizen T, Marrink J.
    Oncodev Biol Med; 1981 Apr 25; 2(1-2):117-28. PubMed ID: 6170952
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ, Norman AR, Dearnaley DP, Horwich A.
    J Clin Oncol; 1995 Jan 25; 13(1):87-92. PubMed ID: 7528272
    [Abstract] [Full Text] [Related]

  • 11. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
    Uysal Z, Bakkaloğlu M.
    Int Urol Nephrol; 1987 Jan 25; 19(4):415-8. PubMed ID: 2448261
    [Abstract] [Full Text] [Related]

  • 12. Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
    Seckl MJ, Rustin GJ, Bagshawe KD.
    Br J Cancer; 1990 Jun 25; 61(6):916-8. PubMed ID: 1695522
    [Abstract] [Full Text] [Related]

  • 13. [Diagnosis, prevalence, prognosis and treatment of the trophoblastic component in germinal tumours of the testis in the adult].
    Ewald N, Roth A, Nezelof C, Cukier J.
    J Urol (Paris); 1982 Jun 25; 88(6):325-35. PubMed ID: 6294186
    [Abstract] [Full Text] [Related]

  • 14. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB, Krauss M, Geyer C, Tannapfel A, Körholz D, Hirsch W.
    Klin Padiatr; 2007 Jun 25; 219(3):146-51. PubMed ID: 17525908
    [Abstract] [Full Text] [Related]

  • 15. Germ cell tumours of testis: prognostic factors and results.
    Nikzas D, Champion AE, Fox M.
    Eur Urol; 1990 Jun 25; 18(4):242-7. PubMed ID: 1705226
    [Abstract] [Full Text] [Related]

  • 16. The growth rate of metastatic non-seminomatous germ cell testicular tumours measured by marker production doubling time--I. Theoretical basis and practical application.
    Price P, Hogan SJ, Horwich A.
    Eur J Cancer; 1990 Apr 25; 26(4):450-3. PubMed ID: 1694086
    [Abstract] [Full Text] [Related]

  • 17. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
    Altug MU, Akdas A, Ruacan S, Ozen AH, Remzi D.
    Br J Urol; 1987 May 25; 59(5):458-62. PubMed ID: 2439163
    [Abstract] [Full Text] [Related]

  • 18. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D, Caillaud JM, Droz JP, Delarue JC, Bohuon C.
    Nouv Presse Med; 1981 Nov 07; 10(40):3293-7. PubMed ID: 6170931
    [Abstract] [Full Text] [Related]

  • 19. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, Escaf Barmadah S, García Rodríguez J, Pérez García FJ, Rodríguez Faba O, Jalón Monzón A.
    Arch Esp Urol; 2002 Oct 07; 55(8):915-22. PubMed ID: 12455282
    [Abstract] [Full Text] [Related]

  • 20. Serum tumour marker regression rate following chemotherapy for malignant teratoma.
    Horwich A, Peckham MJ.
    Eur J Cancer Clin Oncol; 1984 Dec 07; 20(12):1463-70. PubMed ID: 6209145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.